Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 127 | 0 | 0 | 88 | 25 |
| Cost of Goods | 52 | N/A | N/A | 75 | 16 |
| Gross Profit | 75 | N/A | N/A | 13 | 9 |
| Operating Expenses | 13,689 | 9,088 | 1,722 | 153 | 64 |
| Operating Income | -13,561 | -9,088 | -1,722 | -65 | -40 |
| Other Income | 286 | -4 | -393 | 0 | 0 |
| Pre-tax Income | -13,275 | -9,091 | -2,115 | -65 | -40 |
| Net Income Continuous | -13,275 | -9,091 | -2,115 | -65 | -40 |
| Net Income | $-13,275 | $-9,091 | $-2,115 | $-65 | $-40 |
| EPS Basic Total Ops | -0.26 | -0.26 | -0.26 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.26 | -0.26 | -0.26 | -0.01 | -0.03 |
| EPS Diluted Total Ops | -0.26 | -0.26 | -0.26 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.26 | -0.26 | -0.26 | -0.01 | -0.03 |
| EBITDA(a) | $-13,355 | $-8,965 | $-1,646 | $-65 | $-40 |